# OnCo record paper-dreyer-xpert-bladder-dablaca-15-eur-urol-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-dreyer-xpert-bladder-dablaca-15-eur-urol-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-dreyer-xpert-bladder-dablaca-15-eur-urol-2025" ;
  schema:name "Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial"@en ;
  schema:description "A Danish randomised trial in which a urine RNA test was used to decide when people under bladder cancer follow-up needed a camera examination of the bladder."@en ;
  schema:url <https://onco.cc/key-papers/paper-dreyer-xpert-bladder-dablaca-15-eur-urol-2025/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.eururo.2025.03.018>, <https://pubmed.ncbi.nlm.nih.gov/40280776/> ;
  schema:sameAs <https://doi.org/10.1016/j.eururo.2025.03.018> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Dreyer T, Brandt S, Fabrin K, et al." ;
  onco:cancers <https://onco.cc/cancers/non-muscle-invasive-bladder-cancer/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/liquid-rna-biopsy/>, <https://onco.cc/technologies/urine-bladder-cancer-tests/> ;
  onco:drugs <https://onco.cc/drugs/xpert-bladder-cancer-monitor/> ;
  onco:terms <https://onco.cc/terms/biomarker/> .
